Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: Melanoma - The Untold Story

Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia

SAN CARLOS, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that the Therapeutic Goods Administration (TGA) of Australia granted approval with conditions of…

AAP

Melanoma is the deadliest form of skin cancer. A new vaccine-drug combo could slash recurring cases

An estimated 112,000 new melanoma cases and 8,500 deaths are expected this year

The Independent UK

Dermatologists rubbish ‘dangerous’ claims that tanned skin protects against sunburn

Melanoma is the most aggressive form of skin cancer causing about 2,600 deaths a year in the UK – many are linked to sunbed use

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Q&A: Justin Thomas on a Life-Changing Moment, Sun Protection and Shinnecock Hills

The two-time major champion has his own suncare brand, which all started with dermatologist visit back in 2019.

Sports Illustrated

Aura Biosciences Gears Up for Bel-Sar Filing as Pivotal Eye Cancer Trial Advances

Aura Biosciences (NASDAQ:AURA) is shifting its focus toward regulatory preparation and commercialization planning as enrollment in its registrational CoMpass study of bel-sar in early choroidal melanoma nears completion, newly appointed CEO Natalie Holles said during a fireside chat at TD Cowen’s se

MarketBeat

IDEAYA Biosciences Spotlights Darovasertib Win, FDA Review Path at Oncology Summit

IDEAYA Biosciences (NASDAQ:IDYA) executives highlighted recent clinical progress across the company’s oncology pipeline during a fireside chat at TD Cowen’s seventh annual Oncology Innovation Summit, with the discussion focused primarily on darovasertib combinations in uveal melanoma and several ear

MarketBeat

IDEAYA Biosciences Eyes Busy 2026 as Darovasertib Advances Toward FDA Filing

IDEAYA Biosciences (NASDAQ:IDYA) Chief Executive Yujiro Hata said the precision oncology company is preparing for a busy 2026, led by regulatory and clinical milestones for darovasertib in metastatic uveal melanoma and multiple data readouts across its pipeline. Speaking at a Stifel-hosted event, H

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

'It was all through my body': tradie's blunt message for outdoor workers

A big work and safety issue that needs more understanding.

Newcastle Herald

First video of immune cells eating live skin cancer in real time

For the past 15 years or so, a class of drugs called immune checkpoint inhibitors have been used to treat melanoma – the most dangerous kind of skin cancer.

The Conversation

Deadliest Skin Cancer Cases Hit Record High in the UK as Experts Blame Sun Exposure and Sunbed Use

UK melanoma cases hit a record high with 20,000+ yearly diagnoses as experts warn excessive UV exposure and sunbed use raise risks.

International Business Times UK

Melanoma skin cancer cases in UK hit record level, analysis finds

Cancer Research UK figures show number diagnosed with most serious form of skin cancer has risen above 20,000 for first time

The Guardian - UK

Melanoma skin cancer cases hit record high in the UK as heatwave warning issued

Cancer Research UK urged people to enjoy the sun safely by covering up and using sunscreen

The Independent UK

Sun safety warning issued for bank holiday as skin cancer cases hit record high

Cancer Research UK data for the year 2022 shows there were 20,980 new cases of melanoma, the highest number it has ever seen.

Evening Standard

Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data

Aura Biosciences (NASDAQ:AURA) executives outlined the company’s strategy for its lead candidate bel-sar during a session at the H.C. Wainwright Connect Conference, emphasizing ocular oncology as the company’s initial development focus while also discussing ongoing work in non-muscle invasive bladde

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Regeneron Sinks 10% on Failed Phase 3 Melanoma Trial. What Comes Next for REGN Stock.

Regeneron stock sinks as fianlimab Phase 3 trial fails to meet primary endpoint. But RBC continues to see significant upside in REGN shares from here.

MarketBeat

IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data

IDEAYA Biosciences (NASDAQ:IDYA) said its lead oncology program remains on track for a regulatory submission after reporting positive top-line data in first-line metastatic melanoma, while also highlighting several pipeline programs during a presentation at the Bank of America Global Healthcare Conf

The Independent UK

RFK Jr withdraws proposal banning teens from tanning beds as skin experts warn of cancer risks

Using tanning beds can triple a person’s risk of melanoma, according to experts

The Independent UK

Skin cancer warning as one in nine Britons admit to deliberately burning themselves to tan

Research shows that having five or more sunburns doubles your risk of getting melanoma skin cancer

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Teddi Mellencamp claims doctor denied her GLP-1s after weight gain from cancer treatment

The reality star was diagnosed with melanoma in 2022, with her condition advancing to stage four last year

The Independent UK

Your gut bacteria could determine your skin cancer risk - but there’s a catch

Researchers found that differences in the amount of key bacterial groups in the gut predicted cancer recurrence with up to 94% accuracy

Euronews

AI can identify people at risk of melanoma years before diagnosis, study finds

Swedish researchers have used AI to spot high-risk melanoma patients before they develop the disease, using health data from existing medical records.

Sports Illustrated

ESPN Legend Dick Vitale Announces Melanoma Diagnosis: ‘I Plan on Winning This Battle’

Vitale has endured bouts with four different forms of cancer.

The Independent UK

I thought my facial mole was harmless — until my doctor warned it could be skin cancer

Skin cancer is the most common type of cancer, with more than two million cases expected this year. The Independent’s Julia Musto thought she might be one of them

The Conversation

Australian children now have half as many moles as kids in 1992. That’s good news for melanoma risk

About one in two Australians will be diagnosed with skin cancer by age 70. The most dangerous kind is melanoma, which develops in skin cells called melanocytes that have been overexposed to the sun.

BANG Premier

Teddi Mellencamp's daughter given her strength amid cancer fight

Teddi Mellencamp has credited her “miracle baby” Dove with giving her strength and resilience throughout her stage four melanoma battle.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

the American Cancer Society

Regeneron Pharmaceuticals

65 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.